Cargando…
Incidence and cost of treatment-emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study
BACKGROUND: Treatment-emergent comorbid events (TECs) are common In patients initiating treatment with pegylated interferon alpha (PEG-IFN-alfa) and ribavirin for chronic hepatitis C virus (HCV) infection. The purpose of this study was to estimate the incidence and incremental cost of these events....
Autores principales: | Sapra, Sandhya, Chang, Eunice, Broder, Michael S, L’Italien, Gilbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263056/ https://www.ncbi.nlm.nih.gov/pubmed/25249187 http://dx.doi.org/10.1186/1472-6963-14-429 |
Ejemplares similares
-
Measurement properties of the Flu-Like Symptom Index from the Hepatitis Physical Symptom Severity Diary
por: Mathias, Susan, et al.
Publicado: (2013) -
Review of patient-reported outcome measures in chronic hepatitis C
por: Kleinman, Leah, et al.
Publicado: (2012) -
Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria
por: Broder, Michael S., et al.
Publicado: (2015) -
Real‐world assessment of the relationship between migraine‐related disability and healthcare costs in the United States
por: Harris, Linda, et al.
Publicado: (2022) -
Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)